An 87-year-old man with Alzheimer-type dementia presented to our hospital with pain in the right breast. A physical examination revealed nipple discharge and gynecomastia of the right breast ([Picture 1](#g001){ref-type="fig"}, [2](#g002){ref-type="fig"}, arrows). He underwent treatment (1 mg risperidone) for 8 months for night delirium. His prolactin levels were increased \[68.5 (normal: 3.6-12.8) ng/mL\]; however, thyroid function test results were normal. Computed tomography revealed an enlarged right mammary gland. Pituitary magnetic resonance imaging showed no abnormality. Gynecomastia owing to risperidone-induced hyperprolactinemia was diagnosed. Therefore, risperidone, which was deemed the most likely to induce hyperprolactinemia ([@B1]), was discontinued. His breast pain and gynecomastia disappeared within few days ([Picture 3](#g003){ref-type="fig"}, [4](#g004){ref-type="fig"}); however, his delirium worsened. Quetiapine 12.5 mg/day was initiated, which resolved his delirium; the patient\'s prolactin levels were 15.1 ng/mL at 6 months later. Dopamine (D2) receptor blockage by various drugs (especially antipsychotics, antidepressant, and prokinetics) causes increased prolactin secretion ([@B1]). Some atypical antipsychotics (clozapine, aripirazole, olanzapine, and quetiapine) do not increase prolactin secretion because of a low tendency to blockade dopamine receptors as well as a prolactin-sparing effect ([@B1],[@B2]).
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